Drugs / ROVALCYTE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05708508 | Mar 2024 → Apr 2027 expected | disease related to solid organ transplantation | University Hospital, Rouen | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ROVALCYTE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05708508 ↗ |